NewcelX Ltd. (NCEL) vs NEXGEL, Inc. (NXGL)

A side-by-side comparison of NewcelX Ltd. and NEXGEL, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

NCEL

NewcelX Ltd.

$1M

$2.94HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT

NXGL

NEXGEL, Inc.

$1M

$0.17HealthcareDelayed quote: Oct 6, 2026, 1:17 PM EDT

Total return — NCEL vs NXGL

growth of $100 · dividends reinvested · last 5y

NCEL -99.5% (-64.7%/yr)NXGL -95.2% (-45.5%/yr)NXGL compounded faster over this window

Log scale — wide-divergence pair

NCEL NXGL

NCEL vs NXGL: by the numbers

•NXGL is the larger company ($1M vs $1M market cap).
•Both run net losses; NCEL's is the smaller (0.00% vs -51.26% net margin).

Metrics side by side

Valuation

Metric	NCEL	NXGL
P/S ratio	N/A	0.12
P/B ratio	0.22	0.29

Profitability

Metric	NCEL	NXGL
Gross margin	0.00%	35.07%
Operating margin	0.00%	-29.35%
Net margin	0.00%	-51.26%
ROE	-114.48%	-124.97%
ROIC	-32.53%	-41.80%

Growth (annualized)

Metric	NCEL	NXGL
Revenue CAGR (5Y)	N/A	63.69%
Total return CAGR (5Y)	-68.96%	N/A

Go deeper

Full NCEL analysis Full NXGL analysis Interactive comparison tool

Dig into the metrics

NewcelX ROE NEXGEL ROE NewcelX operating margin NEXGEL operating margin NewcelX revenue growth NEXGEL revenue growth NewcelX free cash flow NEXGEL free cash flow

NewcelX & NEXGEL appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.